Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

1,482 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,482 results

Not applicableStudy completedNCT02556307
What this trial is testing

The Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 270
Not applicableWithdrawnNCT00571714
What this trial is testing

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Large-scale testing (Phase 3)Study completedNCT00006164
What this trial is testing

Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment

Who this might be right for
Chronic Hepatitis cCirrhosis, LiverFibrosis, Liver+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,050
Post-approval studies (Phase 4)Study completedNCT06922643
What this trial is testing

Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital

Who this might be right for
Chronic Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 100
Large-scale testing (Phase 3)UnknownNCT02897596
What this trial is testing

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients

Who this might be right for
Hepatitis CHIV
Fundacion Clinic per a la Recerca Biomédica 62
Testing effectiveness (Phase 2)Study completedNCT02349048
What this trial is testing

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C Virus
Janssen Research & Development, LLC 68
Large-scale testing (Phase 3)Study completedNCT00527540
What this trial is testing

Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tehran Hepatitis Center 60
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Not applicableStudy completedNCT02402218
What this trial is testing

CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
Johns Hopkins University 144
Post-approval studies (Phase 4)Study completedNCT03365635
What this trial is testing

Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C

Who this might be right for
Hepatitis CHemodialysisNosocomial Infection
University of Pennsylvania 6
Large-scale testing (Phase 3)Study completedNCT00758043
What this trial is testing

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 540
Post-approval studies (Phase 4)Study completedNCT02781649
What this trial is testing

Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients

Who this might be right for
End-Stage Renal DiseaseHepatitis C
Johns Hopkins University 10
Not applicableStudy completedNCT01711164
What this trial is testing

The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis

Who this might be right for
Chronic Hepatitis C Infection
University Health Network, Toronto 106
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Not applicableEnded earlyNCT01951209
What this trial is testing

Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis

Who this might be right for
Liver CirrhosisChronic Hepatitis C
David E. Kaplan, MD MSc 13
Large-scale testing (Phase 3)Study completedNCT00122616
What this trial is testing

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Who this might be right for
HIV InfectionsHepatitis C, Chronic
French National Agency for Research on AIDS and Viral Hepatitis 52
Large-scale testing (Phase 3)Study completedNCT03186365
What this trial is testing

8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 82
Large-scale testing (Phase 3)Study completedNCT00687219
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 102
Testing effectiveness (Phase 2)Study completedNCT01716156
What this trial is testing

Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 26
Post-approval studies (Phase 4)Study completedNCT00532701
What this trial is testing

Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR

Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 880
Load More Results